Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk Grp T1 Regulatory News (83WK)

Share Price Information for Sant Uk Grp T1 (83WK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.878
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Yest. Close: 97.878
83WK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Santander UK Plc - Publication of Final Terms

Fri, 2nd Mar 2018 15:58

RNS Number : 5937G
Santander UK Plc
02 March 2018
 

 

SANTANDER UK PLC

€30 BILLION EURO MEDIUM TERM NOTE PROGRAMME

PUBLICATION OF FINAL TERMS - SERIES B-1480

 

The following final terms (the Final Terms) are available for viewing:

 

Issue of EUR 720,000,000 Floating Rate Senior Notes due 2020 (ISIN XS1784284975) (Series B-1480) (the Notes), under the €30 billion Euro Medium Term Note programme of Santander UK Group Holdings plc and Santander UK plc (the Programme).

 

To view the full Final Terms document, please click on or paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/5937G_-2018-3-2.pdf

 

A copy of the Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do. This website is not provided for, nor is it directed at, U.S. persons or persons in the United States. If you are a U.S. person, or you are viewing this page from the United States, you should exit this section of the website.

 

For further information, please contact:

 

Medium Term Funding 2 Triton Square Regent's Place London NW1 3AN

 

Tel: +44 (0) 20 7756 7107

 

Email: mtf@santander.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Final Terms and the base prospectus published in respect of the Programme on 30 August 2017, as supplemented on 14 September 2017, 26 October 2017 and 7 February 2018 (the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus you must ascertain from the Final Terms and the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon your compliance with the above requirement.

 

This publication of the Final Terms does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTFKBDPPBKDANK

Login to your account

Don't have an account? Click here to register.